China SXT Pharmaceuticals (SXTC) Change in Accured Expenses (2018 - 2019)
China SXT Pharmaceuticals (SXTC) recorded quarterly Change in Accured Expenses of $701876.0 in Q3 2019, up 1.5% quarter-over-quarter from $691522.0 in Q1 2019, and up 123.26% on a YoY basis from $314371.0 in Q3 2018.
China SXT Pharmaceuticals (SXTC) Change in Accured Expenses (2018 - 2019) Analysis & Trends
China SXT Pharmaceuticals' Change in Accured Expenses history runs 2 years deep, the most recent figure standing at $701876.0 for Q3 2019.
- In Q3 2019, Change in Accured Expenses rose 123.26% year-over-year to $701876.0; the TTM figure through Sep 2019 stood at $701876.0 (up 123.26% YoY), while the FY2025 annual figure was $298762.0, up 654.96% from the prior year.
- Change in Accured Expenses was $701876.0 for Q3 2019 at China SXT Pharmaceuticals, up from $691522.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $701876.0 in Q3 2019 to a low of $314371.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | China SXT Pharmaceuticals | 187.96 Mn | 166.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 701,876.00 |
| Sep 30, 2019 | 701,876.00 |
| Mar 31, 2019 | 691,522.00 |
| Mar 31, 2019 | 691,522.00 |
| Sep 30, 2018 | 314,371.00 |
| Sep 30, 2018 | 314,371.00 |
| Mar 31, 2018 | 416,226.00 |
| Mar 31, 2018 | 416,226.00 |